Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
boston top stories
cancer immunotherapy
5
×
deals
life sciences
national blog main
national top stories
new york blog main
roche
5
×
san francisco blog main
5
×
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
fda
investing
pfizer
president trump
aduro biotech
amgen
What
roundup
bio
drug
crispr
days
today
acquire
acquisitions
agreed
ahead
albert
alliance
alzheimer’s
ambien
american
annual
asco
attendees
attention
big
biggest
billion
biotech
bourla
bristol
broad
buy
calls
camp’s
cancer
cash
ceo
changing
chicago
city
clinical
color
combinations
community’s
companies
Language
unknown
unset
Current search:
roche
×
photo
×
" san francisco blog main "
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
